Applied Nanobiotechnology for Vector-borne Disease Management: Drug Delivery, Diagnostics, and Sustainable Vector Control.

Vector-borne diseases (VBDs) including malaria, dengue, chikungunya, and leishmaniasis continue to pose significant global health issues, especially in tropical and resource-constrained areas. Traditional management methods utilizing chemical pesticides and pharmacological treatments are progressively constrained by resistance, ecological issues, and delays in diagnosis. This study provides a comprehensive overview of nanobiotechnology applications in three essential aspects of vector-borne disease management: tailored therapies, quick diagnostics, and sustainable vector control. Nanocarrier-based drug delivery methods enhance bioavailability and tissue targeting while minimizing toxicity and treatment failure. Nanobiosensors and point-of-care platforms provide quick and precise pathogen detection appropriate for field environments. In vector management, biodegradable nano-larvicides and RNA interference-based methods provide targeted alternatives to broad-spectrum pesticides. The article additionally analyzes translational issues encompassing pharmacokinetics, biodistribution, toxicity, environmental destiny, scalability, regulatory constraints, and economic factors in endemic areas. Priority is given to incorporating nano-enabled technologies into current vector control efforts instead than supplanting established interventions. Future advancement necessitates standardized assessment techniques, field validation, and the creation of cost-effective, environmentally sustainable formulations. Nanobiotechnology offers supplementary tools that enhance surveillance, treatment, and prevention when integrated into coordinated public health frameworks, presenting a viable approach for the sustainable management of vector-borne diseases.